The dvm360® anesthesiology and pain management page is a comprehensive resource for clinical news and insights on the latest in veterinary anesthesia and pain management. This page consists of videos, interviews, articles, podcasts, and research on the advancements and developments of therapies for anesthesiology, pain management, and more.
April 29th 2025
Visible particulate matter was observed in 2 products containing dexmedetomidine hydrochloride injection 0.5 mg/mL for dogs and cats.
Multimodal treatment of canine osteoarthritis (Sponsored by Hill's and Novartis)
July 1st 2009The foundational pieces of multimodal treatment of canine osteoarthritis should include: nonsteroidal anti-inflammatory drugs (NSAIDs), a pet food rich in eicosapentaenoic acid (EPA), and chondroprotective injectable polysulfated glycosaminoglycan (PSGAG). The ultimate goal of a multimodal approach is to provide the maximum quality of extended life with a minimal effective dose of pharmacologics. The optimal multimodal approach is an overlapping of medical and nonmedical management.
A mulitmodal approach to treating canine osteoarthritis beyond NSAIDs (Sponsored by Nestlé Purina)
June 1st 2009This multimodal approach to the osteoarthritis patient will ideally increase pain-free movement, decrease inflammation, decrease stress on joints, and have some chondroprotective attributes.